Ed Miner, MD, FACC
Utah, Chapter President
ACC Governor, Utah

ACC Rockies Chapter Please join our cardiology colleagues at the ACC Annual Meeting, a premier gathering of cardiovascular professionals from around the world. This dynamic conference brings together leading physicians, researchers, healthcare innovators, and industry experts to explore the latest advances in cardiovascular medicine. Attendees will experience cutting-edge clinical education, groundbreaking research presentations, interactive learning sessions, and exceptional networking opportunities focused on improving patient care and advancing the future of heart health.


For more information and to register, please visit: ACC Rockies Chapter Meeting 2026



ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings

RSS Latest in Cardiology from ACC.org

  • Safety of Antiarrhythmic Agents in Breastfeeding Women
    According to the American Academy of Pediatrics (APA) and the World Health Organization (WHO), exclusive breastfeeding is recommended for the first 6 months of infant life, with continuation up to 2 years or as long as mutually desired by the lactating individual and infant.
  • Novel TEER System Safe, Effective For High-Risk Primary MR Patients
    For high-risk patients with primary mitral valve regurgitation (MR), the novel Neonova transcatheter edge-to-edge repair (TEER) system was safe and effective, with a high rate of event-free survival and sustained clinical and echocardiographic improvements through two years, according to a prospective study published June 29 in JACC: Asia.
  • Joint Society Editorial Calls For Science-Based Approach to CV Health Equity
    A joint editorial on behalf of the ACC, American Heart Association, European Society of Cardiology and World Heart Federation calls for a new era of equity-centered cardiovascular care designed to redefine prevention, optimize care delivery and ensure that all patients worldwide benefit equally from the promise of modern cardiovascular medicine.
  • SHaRe Registry Identifies MACE Predictors in Mild HCM
    About one in five patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events (MACE) over seven years of follow-up, according to SHaRe Registry research published July 8 in JACC.
  • PFA Matches RFA on PVI Durability, Shows Low AE Rates in Registry Data
    Two studies published in JACC: Clinical Electrophysiology on June 29 provide new insights on the durability of pulmonary vein isolation (PVI) with pulsed field ablation (PFA) vs. radiofrequency ablation (RFA) in patients with persistent atrial fibrillation (AFib), as well as the safety profile of PFA among patients undergoing their first ablation for AFib.